» Articles » PMID: 12508159

Prognostic Value of Baseline Human Immunodeficiency Virus Type 1 DNA Measurement for Disease Progression in Patients Receiving Nucleoside Therapy

Overview
Journal J Infect Dis
Date 2003 Jan 1
PMID 12508159
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus (HIV) type 1 DNA assay data were obtained at baseline from 111 HIV-1-positive subjects who were treated with nucleosides. Higher baseline DNA level, HIV-1 RNA level, and infectious titer were comparably associated with an increased hazard of disease progression (each P<.03). Only DNA level was significantly associated with survival (adjusted hazard ratio for 1 log(10) higher level, 3.99; 95% confidence interval, 1.44-11.09; P=.008).

Citing Articles

A DNA Regulatory Element Haplotype at Zinc Finger Genes Is Associated with Host Resilience to Small Ruminant Lentivirus in Two Sheep Populations.

Massa A, Mousel M, Durfee C, Herndon M, Hemmerling K, Taylor J Animals (Basel). 2021; 11(7).

PMID: 34206933 PMC: 8300134. DOI: 10.3390/ani11071907.


Association between cellular HIV-1 DNA level and mortality in HIV-1 infected African adults starting ART with high CD4 counts.

Ntakpe J, Gabillard D, Moh R, Gardiennet E, Emieme A, Badje A EBioMedicine. 2020; 56:102815.

PMID: 32512517 PMC: 7276518. DOI: 10.1016/j.ebiom.2020.102815.


Cell-associated HIV-1 RNA predicts viral rebound and disease progression after discontinuation of temporary early ART.

Pasternak A, Grijsen M, Wit F, Bakker M, Jurriaans S, Prins J JCI Insight. 2020; 5(6).

PMID: 32097124 PMC: 7213790. DOI: 10.1172/jci.insight.134196.


Total HIV DNA: a global marker of HIV persistence.

Rouzioux C, Avettand-Fenoel V Retrovirology. 2018; 15(1):30.

PMID: 29615133 PMC: 5883363. DOI: 10.1186/s12977-018-0412-7.


Total HIV-1 DNA, a Marker of Viral Reservoir Dynamics with Clinical Implications.

Avettand-Fenoel V, Hocqueloux L, Ghosn J, Cheret A, Frange P, Melard A Clin Microbiol Rev. 2016; 29(4):859-80.

PMID: 27559075 PMC: 5010749. DOI: 10.1128/CMR.00015-16.